Results 241 to 250 of about 180,995 (352)
The Role of TNF-α in Neuropathic Pain: An Immunotherapeutic Perspective. [PDF]
Life (Basel)García-Domínguez M.
europepmc +1 more source
The Effects of COVID‐19 on Voice
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.ABSTRACT The COVID‐19 pandemic had profound effects on vocal health, impacting both infected individuals, professional voice users and essential workers. The objective of this paper was to explore the multifaceted nature of dysphonia associated with COVID‐19, arising from both direct and indirect consequences of the pandemic.
Mausumi Syamal
wiley +1 more source
Nano-Anesthetics Regulate Neuro-Immune Interaction for Treating Neuropathic Pain. [PDF]
Adv Sci (Weinh)Wang Y +9 more
europepmc +1 more source
The Prevalence and Severity of Pain in Patients With Systemic Sclerosis
The Journal of Dermatology, EarlyView.ABSTRACT We investigated pain prevalence and severity in systemic sclerosis (SSc) and patient–physician perceptions. This was an internet‐based survey that compared perceptions of pain type, location, severity, associated factors between patients with SSc and physicians, and pain treatment prescription patterns in Japan in March 2023.
Sei‐ichiro Motegi +6 more
wiley +1 more source
Sphenopalatine ganglion stimulation for the treatment of trigeminal neuropathic pain. [PDF]
Front NeurolSokal P +7 more
europepmc +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Psoriatic arthritis (PsA) is a chronic inflammatory disease, with prevalence among psoriasis patients ranging from 6% to 42% across populations. Although targeted therapies such as adalimumab (ADA), secukinumab (SEC), and upadacitinib (UPA) have demonstrated efficacy in randomized controlled trials, real‐world head‐to‐head comparisons remain ...
Yiyi Wang +11 more
wiley +1 more source
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi +4 more
wiley +1 more source